Otsuka Wins Block On Cancer Drug Lonsurf's Generic Version
Otsuka Holdings Co. Ltd.'s Taiho unit nabbed a win Tuesday when a Delaware federal judge upheld its patent for the metastatic colorectal cancer drug treatment Lonsurf, likely keeping a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article